Back to Directory
Last Updated: 06/05/2026
4C Biomed
London
Founded 2016
Immuno-oncology target discovery and antibody therapeutics developer
4C Biomed is a biotechnology company developing immuno-oncology therapies and target discovery platforms based on patient-derived tumour and immune cell systems.
The company uses integrated screening technologies and clinical data to identify novel immune targets and develop antibody therapeutics designed to enhance anti-tumour immune responses.
Its pipeline includes monoclonal antibody candidates targeting immune checkpoint pathways, with lead programmes progressing toward early-stage clinical development.